| Year | 2025 |
|---|---|
| Code | 8631 |
| Campus | Bologna |
| Credits | 3 |
| Cost | 100,00 € |
| Starting date | Jun 23, 2025 |
| Finishing date | Jun 27, 2025 |
| Application deadline | Jun 16, 2025 |
- Course overview
- The Summer School, which will last for 5 days, will be taught in English. It awards 3 University educational credits (CFU) and has as its learning outcome In the last decade we have witnessed changes in the design and conduction of research in the biomedical field, resulting from the decoding of the human genome. In particular , it is relevant that the revolution has been focused on the discovery of new drugs and new drug targets thanks to genomics, transcriptomics and proteomics. The selection and validation of new drug targets requires a number of research strategies that have been developed recently. The aim of the School is to spread among young people in education and among those who are already working in this field, how to best use the tools offered by the most advanced research and updated . Experts, leaders in their field, were invited as lecturers. They will explain, through lectures and a lab exercise, the following topics: chemogenomics, drug discovery, genomics; the role of high-throughput assays; the small interfering RNA; reporter gene models in vitro and in vivo; transcription factors as new therapeutic targets; chemiluminescence Integrated systems for analysis. Finally, we will sketch the lines of the future development of these technologies. In order to better facilitate the dialogue between teachers and students, there are two moments in the middle and at the end of the course, in which students will be encouraged to ask teachers questions on the topics that most interested them. Another highlight will be the individual experience in the laboratory, where each student will engage in experiments planned under the guidance of specialized tutor.
- Subject area
- Sciences and technology
- Number of participants
- min 8 max 50
- Duration
- 5 days
- Language
- English
- Admission qualifications
- - Bachelor and/or two-year Master degrees awarded pursuant to Ministerial Decree 270/04 (or first-cycle and/or second-cycle degrees awarded under the degree programme systems in force prior to Ministerial Decree DM 509/99) in the following disciplinary areas/degree programme classes: L-2 Biotechnologies, Genomics, L-13 Biology, L-29 Pharmacy,LM-6 Biology, LM-8 Industrial Biotechnologies, LM-9 Pharmaceutical, Veterinary and Medical biotechnologies, LM-13 Pharmacy and industrial pharmacy, LM-41 Medicine, LM-54 Chemistry;
- Students enrolled in the 4th years of LM13
- Bachelor and/or two-year Master degrees awarded abroad in the above-said disciplinary areas and valid for admission to the Programme.
- Other single cycle master's degrees may be considered according to the candidate's specific curriculum and skills - Linguistic skills
- attestation or self-certification of knowledge of the English language level A2
- Academic director
- Prof. Gabriele Campana
- Study plan
-Intellectual property and biotechnological innovation
-Biased agonism at GPCRs, integrin and neurodegenerative disease
-Bioinformatics
-HIV Therapeutic Strategies
-Genetic and epigenetic pathways in drug discovery: Nuclear receptors as pharmacologicaltarget-Probing Allosteric Communication with Combined Molecular Dynamics Simulations and Network Analysis